Clinton C. Bertram

491 total citations
14 papers, 365 citations indexed

About

Clinton C. Bertram is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, Clinton C. Bertram has authored 14 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 5 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Clinton C. Bertram's work include Psoriasis: Treatment and Pathogenesis (5 papers), Spondyloarthritis Studies and Treatments (5 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). Clinton C. Bertram is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (5 papers), Spondyloarthritis Studies and Treatments (5 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). Clinton C. Bertram collaborates with scholars based in United States, Germany and Canada. Clinton C. Bertram's co-authors include Michelle T. Barati, Jon B. Klein, Sandra S. Zinkel, Grzegorz M. Boratyn, Linda Ficociello, Brad H. Rovin, Grier P. Page, Bruce A. Perkins, Daniel W. Wilkey and Andrzej S. Królewski and has published in prestigious journals such as Journal of the American Society of Nephrology, Cell Death and Differentiation and Annals of the Rheumatic Diseases.

In The Last Decade

Clinton C. Bertram

13 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clinton C. Bertram United States 10 119 109 109 90 53 14 365
Jennifer Hawkins United States 7 121 1.0× 144 1.3× 82 0.8× 214 2.4× 14 0.3× 8 525
Kazuhito Fukuoka Japan 8 56 0.5× 60 0.6× 62 0.6× 28 0.3× 33 0.6× 23 216
Gopala K. Rangan Australia 10 141 1.2× 95 0.9× 30 0.3× 285 3.2× 29 0.5× 13 481
Haoqiang Hu China 5 118 1.0× 219 2.0× 79 0.7× 105 1.2× 28 0.5× 8 335
Juliana Cazarin Brazil 13 41 0.3× 180 1.7× 68 0.6× 30 0.3× 22 0.4× 19 440
Yoshitaka Koshino Japan 8 59 0.5× 39 0.4× 52 0.5× 229 2.5× 36 0.7× 28 333
Marie-Noëlle Peraldi France 9 106 0.9× 72 0.7× 19 0.2× 154 1.7× 57 1.1× 10 402
Sigitas Urbonavičius Denmark 13 50 0.4× 68 0.6× 12 0.1× 31 0.3× 16 0.3× 22 428
Holly Hutton Australia 7 85 0.7× 171 1.6× 33 0.3× 128 1.4× 10 0.2× 12 341
Osamu Yonekawa Japan 9 24 0.2× 89 0.8× 25 0.2× 17 0.2× 82 1.5× 19 322

Countries citing papers authored by Clinton C. Bertram

Since Specialization
Citations

This map shows the geographic impact of Clinton C. Bertram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clinton C. Bertram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clinton C. Bertram more than expected).

Fields of papers citing papers by Clinton C. Bertram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clinton C. Bertram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clinton C. Bertram. The network helps show where Clinton C. Bertram may publish in the future.

Co-authorship network of co-authors of Clinton C. Bertram

This figure shows the co-authorship network connecting the top 25 collaborators of Clinton C. Bertram. A scholar is included among the top collaborators of Clinton C. Bertram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clinton C. Bertram. Clinton C. Bertram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Eder, Lihi, Hans‐Peter Tony, Mariusz Korkosz, et al.. (2022). Responses to Ixekizumab in Male and Female Patients with Psoriatic Arthritis: Results from Two Randomized, Phase 3 Clinical Trials. Rheumatology and Therapy. 9(3). 919–933. 12 indexed citations
2.
Orbai, Ana‐Maria, Jordi Gratacós, Anthony Turkiewicz, et al.. (2020). Efficacy and Safety of Ixekizumab in Patients with Psoriatic Arthritis and Inadequate Response to TNF Inhibitors: 3-Year Follow-Up (SPIRIT-P2). Rheumatology and Therapy. 8(1). 199–217. 13 indexed citations
3.
Dougados, Maxime, James Cheng‐Chung Wei, Robert Landewé, et al.. (2019). Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W). Annals of the Rheumatic Diseases. 79(2). 176–185. 86 indexed citations
4.
Guenther, Lyn, Alison Potts Bleakman, Jamie Weisman, et al.. (2019). Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial. Acta Dermato Venereologica. 100(1). 1–9. 21 indexed citations
5.
Tony, Hans‐Peter, E. Galíndez, Chen‐Yen Lin, et al.. (2019). SAT0396 IMPROVEMENT IN THE SIGNS AND SYMPTOMS OF PSORIATIC ARTHRITIS WITH IXEKIZUMAB COMPARED TO PLACEBO IN PATIENT SUBGROUPS DEFINED BY BASELINE DISEASE CHARACTERISTICS. Annals of the Rheumatic Diseases. 78. 1285–1285. 3 indexed citations
7.
Bertram, Clinton C., Aurélia Vergeade, Daniel S. Lark, et al.. (2018). Bid maintains mitochondrial cristae structure and function and protects against cardiac disease in an integrative genomics study. eLife. 7. 21 indexed citations
8.
Vergeade, Aurélia, Clinton C. Bertram, Alfiya Bikineyeva, et al.. (2016). Cardiolipin fatty acid remodeling regulates mitochondrial function by modifying the electron entry point in the respiratory chain. Mitochondrion. 28. 88–95. 28 indexed citations
9.
Bertram, Clinton C., et al.. (2011). Animal models of maternal nutrition and altered offspring bone structure – Bone development across the lifecourse. European Cells and Materials. 22. 321–332. 19 indexed citations
10.
Bertram, Clinton C., et al.. (2010). Proapoptotic Bid mediates the Atr-directed DNA damage response to replicative stress. Cell Death and Differentiation. 18(5). 841–852. 25 indexed citations
11.
Merchant, Michael L., Bruce A. Perkins, Grzegorz M. Boratyn, et al.. (2009). Urinary Peptidome May Predict Renal Function Decline in Type 1 Diabetes and Microalbuminuria. Journal of the American Society of Nephrology. 20(9). 2065–2074. 110 indexed citations
12.
Powell, David W., Clinton C. Bertram, Timothy D. Cummins, et al.. (2008). Renal Tubulointerstitial Fibrosis in OVE26 Type 1 Diabetic Mice. Nephron Experimental Nephrology. 111(1). e11–e19. 22 indexed citations
13.
Graß, H., Clinton C. Bertram, A Schuff, & R. Dettmeyer. (2006). Die intramuskuläre Injektion. Rechtsmedizin. 16(3). 161–164. 3 indexed citations
14.
Graß, H., A Schuff, Clinton C. Bertram, & Markus A. Rothschild. (2004). Die intramuskuläre Applikation von Diclofenac - Fallbericht und kritische Betrachtung einer therapeutischen Maßnahme. Zeitschrift für Orthopädie und ihre Grenzgebiete. 142(4). 489–492. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026